ACCC
GSK in the clear
Panadol Osteo pricing statement ambiguous, but not false or misleading: ACCC The Australian Competition and Consumer Commission has concluded its investigation into whether GlaxoSmithKline (GSK) made misleading statements about a …
Pharmacies warned after Chemmart ACCC decision
The ACCC has accepted an administrative undertaking on behalf of Chemmart following concerns about its myDNA genetic test The ACCC says it was concerned that statements in Chemmart’s catalogues, television …
Dodgy CAM Claims: where does the hype end and health fraud begin?
Pharmacy has a lot to learn from the Sensaslim debacle—but is it interested in doing so? wonders Ian Carr A short few years ago, one Groundhog Day in the diet …
Heinz taken to court over toddler foods
Products that claim to be healthy contain over 60% sugar, alleges the Australian Competition and Consumer Commission The ACCC has commenced proceedings in the Federal Court against the Australian arm …
ACCC takes e-cigarette retailers to court
The Australian Competition and Consumer Commission has commenced separate proceedings in the Federal Court against two e-cigarette online retailers alleging that they made false or misleading representations and engaged in …
AMA welcomes ACCC action against Medibank
The AMA welcomes the Australian Competition and Consumer Commission’s decision to launch legal action against Medibank Private over alleged misleading and deceptive conduct. AMA President Dr Michael Gannon says the …
ACCC appeals $1.7m Nurofen penalty
Consumer watchdog says fine is inadequate deterrent. The Australian Competition and Consumer Commission (ACCC) is appealing the federal court’s decision to fine Reckitt Benckiser $1.7 million for its Nurofen Specific Pain …
Panadol Osteo referral: a first for the Minister
It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for …
ACCC okays Pfizer’s Hospira acquisition
The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest …
MA to strengthen public reporting
The Australian Competition and Consumer Commission is requiring Medicines Australia to strengthen its public reporting as a part of authorising edition 18 of its Code of Conduct for five years. …
GSK, Novartis get ACCC okay to restructure
The Australian Competition and Consumer Commission says it won’t oppose GlaxoSmithKline’s and Novartis’ transactions involving over-the-counter consumer products, human vaccines and oncology products. As a result of the transactions: GSK …